|
Current issue
Archive
Online First
About the journal
Editorial board
Editorial office
Publisher
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
|
1/2005
vol. 4 abstract:
Micronized progesterone. Its features and application in gynecology and obstetrics
Alina Warenik-Szymankiewicz
,
Błażej Męczekalski
Prz Menopauz 2005; 1: 15–19
Online publish date: 2005/02/15
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Progesterone together with estradiol is one of the most important steroid hormone responsible for reproductive functions in women. Progesterone is produced in the ovary, testis, adrenal glands, central nervous system and placenta. The use of the natural progesterone in the hormonal therapy was difficult. It was related to the fast metabolism of natural progesterone and its weak bioavailibility. The use of progestinsgave the hope for the safe and effective therapy. It was appeared, that the use of progestins is associated with the numerous metabolic side effects such as: sodium retention in the system, disturbances in the glucose tolerance, bleeding, secondary amenorrhea. Therefore the use of micronized progesterone seems to be very promising. The chemical structure of micronized progesterone is identical with natural progesterone. The micronization process improved progesterone bioavailibility and effectivness. Micronized progesterone preparations can be used in the treatment of menstrual disorders, hormonal replacement therapy, osteoporosis, premenstrual syndrome and therapy of pregnancy maintenance.
keywords:
progesterone, menopause, ammenorrhea, endomerium, hormonal replacement therapy |